United States · FDA National Drug Code directory
Alrex
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 24208-353_138577af-1a4e-48fb-b088-47f54c896442
- Product NDC
- 24208-353
- Form
- SUSPENSION/ DROPS
- Composition / generic term
- loteprednol etabonate
- Labeler
- Bausch & Lomb Incorporated
- Marketing category
- NDA
- Marketing start / end (source format)
- 19980309
- Source listing expiry
- 20261231
Source-listed ingredients
- LOTEPREDNOL ETABONATE — 2 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE, DROPPER in 1 CARTON (24208-353-01) / 1 mL in 1 BOTTLE, DROPPER · 24208-353-01
- 1 BOTTLE, DROPPER in 1 CARTON (24208-353-05) / 5 mL in 1 BOTTLE, DROPPER · 24208-353-05
- 1 BOTTLE, DROPPER in 1 CARTON (24208-353-10) / 10 mL in 1 BOTTLE, DROPPER · 24208-353-10
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →